This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Murray, Frank & Sailer LLP Investigates Breaches Of Fiduciary Duty Regarding Acquisition Of Drugstore.com, Inc. By Walgreen Co.

Stocks in this article: DSCM

Murray, Frank & Sailer LLP is investigating claims of breach of fiduciary duty by certain members of the board of directors of drugstore.com, inc. (NASDAQ: DSCM) (“drugstore.com” or the “Company”) in relation to the acquisition of the Company by Walgreen Co. (“Walgreen”).

On March 24, 2011, drugstore.com and Walgreen announced that Walgreen will acquire drugstore.com pursuant to a transaction under which drugstore.com stockholders will receive $3.80 in exchange for each share of drugstore.com common stock, an aggregate value of approximately $409 million. The transaction is expected to close in July 2011.

The investigation concerns whether certain members of the board of directors breached their fiduciary duty in connection with their efforts to sell drugstore.com to Walgreen at an inadequate price through an unfair process which significantly undervalues the Company. In particular, as recently as May 2010, drugstore.com shares traded as high as $3.91 per share. For this and other reasons, Murray Frank is investigating whether the acquisition price will fairly compensate drugstore.com shareholders.

If you are a current investor in drugstore.com, who purchased DSCM shares before March 24, 2011, and you wish to discuss this investigation or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Bridget Hamill at (800) 497-8076 or (212) 682-1818, or by email at investigations@murrayfrank.com.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,490.58 -188.12 -1.06%
S&P 500 2,036.55 -20.54 -1.00%
NASDAQ 4,707.0240 -64.7390 -1.36%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs